| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $19.20 | $0.00 | Buy | 9 | 2026 |
#2 | MMED | United States | $11.73 | $0.00 | Strong Buy | 10 | 2026 |
#3 | AA | United States | $62.80 | $12,831,000,000.00 | Buy | 10 | 2016 |
#4 | AR | United States | $36.14 | $5,275,823,000.00 | Buy | 16 | 2013 |
#5 | EQT | United States | $56.25 | $8,644,211,000.00 | Buy | 21 | 1994 |
#6 | NFG | United States | $80.12 | $2,277,541,000.00 | Buy | 4 | 1997 |
#7 | GMED | United States | $85.94 | $2,938,931,000.00 | Buy | 14 | 2012 |
#8 | TMDX | United States | $72.55 | $605,494,000.00 | Buy | 9 | 2019 |
#9 | SHAK | United States | $69.51 | $1,445,306,000.00 | Buy | 26 | 2014 |
#10 | PTCT | United States | $64.49 | $264,734,000.00 | Buy | 17 | 2006 |
#11 | DAN | United States | $34.70 | $7,500,000,000.00 | Buy | 5 | 1998 |
#12 | FRPT | United States | $55.64 | $1,102,015,000.00 | Buy | 17 | 2014 |
#13 | APEI | United States | $54.63 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#14 | NVST | United States | $24.41 | $2,566,500,000.00 | Buy | 13 | 2019 |
#15 | ALHC | United States | $18.24 | $3,948,719,000.00 | Buy | 8 | 2021 |
#16 | STOK | United States | $32.72 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#17 | ARQT | United States | $20.56 | $376,072,000.00 | Strong Buy | 6 | 2020 |
#18 | REPX | United States | $34.08 | $3,038,000.00 | Strong Buy | 4 | 2003 |
#19 | AMLX | United States | $15.21 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#20 | LASR | United States | $66.81 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#21 | IDYA | United States | $28.28 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#22 | AZTA | United States | $18.40 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#23 | ARVN | United States | $10.13 | $262,600,000.00 | Buy | 19 | 2018 |
#24 | CSV | United States | $44.52 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#25 | IMNM | United States | $22.08 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#26 | HG | Bermuda | $30.72 | $2,905,524,000.00 | Buy | 8 | 2023 |
#27 | USFD | United States | $87.38 | $39,424,000,000.00 | Buy | 11 | 2016 |
#28 | MAMA | United States | $13.43 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#29 | BFAM | United States | $68.56 | $1,903,182,000.00 | Buy | 7 | 2012 |
#30 | W | United States | $66.28 | $0.00 | Buy | 28 | 2014 |
#31 | CRTO | France | $16.41 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#32 | ERAS | United States | $10.32 | $0.00 | Strong Buy | 12 | 2021 |
#33 | RIVN | United States | $14.18 | $5,387,000,000.00 | Buy | 21 | 2021 |
#34 | PPL | United States | $36.69 | $9,042,000,000.00 | Buy | 13 | 2007 |
#35 | RLAY | United States | $12.51 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#36 | MDT | Ireland | $78.08 | $33,537,000,000.00 | Buy | 21 | 2014 |
#37 | MRBK | United States | $18.09 | $6,316,000.00 | Strong Buy | 4 | 2018 |
#38 | ITRI | United States | $81.05 | $2,367,194,000.00 | Buy | 11 | 1996 |
#39 | RVLV | United States | $20.38 | $1,225,682,000.00 | Buy | 12 | 2018 |
#40 | FLS | United States | $71.39 | $0.00 | Strong Buy | 11 | 2006 |
#41 | OLLI | United States | $81.79 | $2,649,198,000.00 | Strong Buy | 13 | 2015 |
#42 | FTI | United States | $70.86 | $9,932,600,000.00 | Buy | 13 | 2016 |
#43 | NI | United States | $46.93 | $0.00 | Buy | 10 | 2018 |
#44 | PEG | United States | $77.60 | $12,168,000,000.00 | Buy | 12 | 1994 |
#45 | KTOS | United States | $56.93 | $751,900,000.00 | Strong Buy | 18 | 1999 |
#46 | APG | United States | $44.72 | $0.00 | Strong Buy | 8 | 2019 |
#47 | KBR | United States | $33.39 | $5,767,000,000.00 | Buy | 8 | 2006 |
#48 | ATMU | United States | $54.93 | $1,764,300,000.00 | Buy | 4 | 2023 |
#49 | OGS | United States | $85.12 | $2,578,005,000.00 | Buy | 9 | 2013 |
#50 | SNDX | United States | $20.44 | $172,352,000.00 | Strong Buy | 13 | 2014 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (May 8, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.